Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference

  Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology
                             Snowbird Conference

PR Newswire

UNION CITY, Calif., Feb. 15, 2013

UNION CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood analysis
systems, announced today that Don Wood, Chief Operations Officer, will
participate in the Lazard Capital Markets 5^th Annual Medical Technology
Snowbird Conference.

The event is being held from February 27 - March 1, 2013 at The Cliff Hotel,
Snowbird Ski and Summer Resort in Snowbird, Utah. The conference format
consists of a full day of one-on-one meetings and will not be webcast.

Institutional investors that wish to request a meeting with Abaxis, Inc.
should contact Lazard Capital Markets.

About Abaxis

Abaxis develops, manufactures, markets and sells portable blood analysis
systems for use in any veterinary or human patient-care setting to provide
clinicians with rapid blood constituent measurements. The system consists of
a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the chemicals
required to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma samples. The
system provides test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. The veterinary
business also provides to the animal health and research market a line of
hematology instruments for point-of-care complete blood counts (CBC), a
specialty instrument to screen for and detect clotting disorders and to
measure equine fibrinogen levels, a handheld instrument for the rapid
assessment of certain critical care tests and rapid point-of-care tests for
Heartworm infections, Parvovirus, Giardia and Lyme disease. Abaxis, through
its AVRL division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.

Contact: Abaxis, Inc.            Lytham Partners, LLC
         Clint Severson          Joe Dorame, Robert Blum and Joe Diaz
         Chief Executive Officer 602-889-9700
         510-675-6500

SOURCE Abaxis, Inc.

Website: http://www.abaxis.com